From November 2020, it is likely that Royal Orthopaedic Hospital will commence making TCAM referrals to community pharmacy followed by Birmingham and Solihull Mental Health Trust in early 2021.
The Local LPC will be hosting an evening virtual event to provide details of how the service will affect you:
• Key benefits to patients, hospital and community pharmacy
• Real case studies
• Operational aspects including PharmOutcomes™ process
It is important ALL community pharmacists book-in and attend this event as it represents an important milestone for pharmacies.
Community pharmacy and hospital pharmacy colleagues in Birmingham and Solihull STP have been working together with West Midlands AHSN to try and improve care for recently discharged patients where it is thought there would be potential benefit of a further intervention. Transfer of Care Around Medicines (TCAM) will be a new service which aims to ensure patients receive appropriate support from their community pharmacist soon after leaving hospital by using PharmOutcomes™ to pass messages securely to and from the hospital and community pharmacy.
Hospital pharmacists will use PharmOutcomes™ to refer patients nearing discharge to the patients chosen local community pharmacy. Patient information will be sent electronically to the community pharmacy and will include: date of birth, postcode, NHS number, GP details and details of discharge medicines. A member of the community pharmacy team will then contact the patient ideally within three days, to arrange for them to receive a consultation. This consultation may then result in the completion of a Medicines Use Review (until they are phased out), New Medicine Service and/or other suitable services; such as repeat dispensing, home delivery, stop smoking, flu vaccination etc...
This is currently not a nationally commissioned service, however can potentially lead to the important provision of other advanced or enhanced commissioned services by community pharmacies. It is also expected that the service will become the new discharge medicines service (DMS) IN 2021.
Evidence has shown real benefits to patients receiving such interventions through reduced readmission rates back into hospital and improved health outcomes. The Pharmaceutical Journal has published an article about a similar scheme which you may wish to read.
Who should attend?
Accessing the webinar
Registrants will receive a link to access the session 1 week and again 1 hour before the session begins. Along with the link to attend, you will also get the following information:
If you have not received your link by Thursday 29th October, please contact firstname.lastname@example.org
Reasonable Adjustments or Access Requirements
The WMAHSN team are keen to ensure each of our events are accessible to all. For those who require reasonable adjustments, please can we ask to you advise your specific requirements in the booking process. Alternatively, please contact email@example.com to discuss your needs in greater detail